 |
인쇄하기
취소
|
Domestic drug makers skimping on R&D investment
Despite their relatively large assets, the nation’s 50 Korean pharmaceutical companies spend considerably less on research and development (R&D), industry data showed recently.
Citing the data released by the Financial Supervisory Service (FSS), Yakup.com, a pharmaceutical information portal, said that R&D spending of 50 local firms listed in Korean Stock Exchange stood at 737.3 billion won...
Citing the data released by the Financial Supervisory Service (FSS), Yakup.com, a pharmaceutical information portal, said that R&D spending of 50 local firms listed in Korean Stock Exchange stood at 737.3 billion won...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.